Imgatuzumab in Patients With Advanced Cutaneous Squamous Cell Carcinoma

Condition:   Cutaneous Squamous Cell Carcinoma Intervention:   Drug: Imgatuzumab Sponsors:   Pega-One S.A.S.;   ICON plc Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials